Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationPaul B. Chapman, Grant A. McArthur, Axel Hauschild et al.|New England Journal of Medicine|2011Cited by 7.7k
Inhibition of Mutated, Activated BRAF in Metastatic MelanomaKeith T. Flaherty, Paul B. Chapman, Igor Puzanov et al.|New England Journal of Medicine|2010Cited by 3.5k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, K. B. Nolop, Chao Zhang et al.|Nature|2010Cited by 1.8k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chipShannon L. Stott, Mehmet Toner, Chia‐Hsien Hsu et al.|Proceedings of the National Academy of Sciences|2010Cited by 1.6k
Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor CellsEmre Ozkumur, Mehmet Toner, Ajay M. Shah et al.|Science Translational Medicine|2013Cited by 1.1k